Stopping the spread of ovarian cancer

Stopping the spread of ovarian cancer
Credit: Freshscience

Molecules that are important for a developing fetus have also been shown to drive the spread of ovarian cancer in adult women, according to Sydney researchers.

In Australia, one woman will die from every 10 hours. The survival rate for women with the disease has remained at 30 per cent for years, as chemotherapy remains the only treatment option.

"These specialised —called RORs—govern the way our limbs, hear and brain form when we're a developing fetus," says researcher Dr. Claire Henry from the University of New South Wales. "They sit on the surface of our cells, and activate a range of cellular processes."

However once we reach full development as adults, the molecules are no longer required and are switched off.

"Our research has shown that they are switched back on in ovarian cancer, however this time with a far more sinister purpose—to drive the spread of the disease around the body," says Claire.

The molecules has also been found in the supporting tissue that surrounds cancer, called .

"This stroma can become inflamed which further enhances the growth and spread of ovarian cancer," Claire says.

However the presence of these molecules in both the cancer and surrounding stroma is a weakness the researchers hope new treatments will be able to exploit.

"Treatments which specifically target these molecules could offer new hope for treating this devastating disease," says Claire.

Explore further

Ovarian cancer cells switched off by 'unusual' mechanism

Provided by Freshscience
Citation: Stopping the spread of ovarian cancer (2018, July 18) retrieved 24 October 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors